Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
American Journal of Ophthalmology|February 8, 2011
Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathyIchiro Maruko, Tomohiro Iida, Yukinori Sugano, et al.
Retina (Philadelphia, Pa.)|September 1, 2011
One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathyIchiro Maruko, Tomohiro Iida, Yukinori Sugano, et al.
Investigative Ophthalmology & Visual Science|October 8, 2011
Autofluorescence of the cells in human subretinal fluidTetsuju Sekiryu, Yasuharu Oguchi, Seisuke Arai, et al.
Investigative Ophthalmology & Visual Science|May 4, 2010
Infrared fundus autofluorescence and central serous chorioretinopathyTetsuju Sekiryu, Tomohiro Iida, Ichiro Maruko, et al.
Japanese Journal of Ophthalmology|February 15, 2013
Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathyYukinori Sugano, Tomohiro Iida, Ichiro Maruko, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 10, 2013
Retinal pigment epithelium tear after intravitreal aflibercept injectionMasaaki Saito, Mariko Kano, Kanako Itagaki, et al.
Frontiers in Immunology|April 14, 2025
Roles of MASP-1 and MASP-3 in the development of retinal degeneration in a murine model of dry age-related macular degenerationTomoko Omori, Takeshi Machida, Yumi Ishida, et al.
Retina (Philadelphia, Pa.)|April 14, 2011
Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathyIchiro Maruko, Tomohiro Iida, Yukinori Sugano, et al.
Retina (Philadelphia, Pa.)|August 1, 2014
Switching to intravitreal aflibercept injection for polypoidal choroidal vasculopathy refractory to ranibizumabMasaaki Saito, Mariko Kano, Kanako Itagaki, et al.
Pageof 12